Masayuki Takeda

6PUBLICATIONS
17CO-AUTHORS
Aged care nursingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2023
Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma.

Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda

|Nov 18, 2021
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.

Akito Hata, Isamu Okamoto, Naoki Inui

|Dec 21, 2020
Interstitial lung disease associated with capmatinib therapy in a patient with non-small cell lung cancer harboring a skipping mutation of MET exon 14.

Hiroaki Kanemura, Masayuki Takeda, Shigeki Shimizu

|Dec 16, 2020
Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai

|Feb 06, 2020
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.

Takayuki Takahama, Koichi Azuma, Mototsugu Shimokawa

|Aug 17, 2019
Tumor tissue and plasma levels of AXL and GAS6 before and after tyrosine kinase inhibitor treatment in EGFR-mutated non-small cell lung cancer.

Yoshikane Nonagase, Masayuki Takeda, Koichi Azuma

Pageof 1

Frequent Collaborators

2 joint publications

Takayuki Takahama

2 joint publications

Isamu Okamoto

1 joint publications

Hiroaki Akamatsu

1 joint publications

Akira Ono